Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of new small-molecule drug candidates for the treatment of patients suffering from fibrotic respiratory diseases and other fibrotic or inflammatory diseases that have high medical needs. dissatisfied. The company is headquartered in Laval, Canada.